Jupiter Life Line Hospitals Ltd

- Jupiter Life Line Hospitals plans to fund its expansion primarily through internal accruals generated over the next 4-5 years combined with debt, maintaining a self-imposed debt ceiling of up to 3 times EBITDA. - The management expects this mix of internal accruals and manageable debt to sufficiently cover capex requirements for ongoing and upcoming projects like Dombivli, Pune South, Mira Road, and BKC. - There is no explicit mention of raising new equity capital in the current or near future. - The company has already paid 25% of the land cost for the Mumbai BKC project and expects to complete remaining payments within this financial year, funded through the same internal accrual and debt strategy.

- INR 500 crores capex deployed in FY26, including Dombivli hospital, BKC land payment, and ongoing Pune and Mira Road projects. - Expansion plans include increasing bed capacity from 1,200 to nearly 2,900 beds in next few years, with around 1,700 new beds across 4 hospitals (Dombivli to BKC). - BKC project: 400-bed quaternary care hospital on over 1 lakh square feet in a premium Mumbai location; land allotted and initial payment done; full land payment to be completed in this financial year. - Mira Road project: Architectural drawings done, regulatory clearances underway, excavation expected to begin by year-end. - Pune South hospital on track to open by calendar year 2028. - Capex funding planned through internal accruals over the next 4-5 years plus debt, maintaining a self-imposed ceiling of 3x EBITDA. - Focus on "asset-heavy" owned infrastructure for long-term operational stability.

- Thane hospital expected to grow at inflation-linked rates at current capacity. - Pune hospital has potential for growth via increased occupancy and inflation-linked price adjustments. - Indore facility is in ramp-up phase with occupancy currently under 50%, expected to mature over 2-3 years; growth to come from improved occupancy and better case mix. - Overall base business is expected to grow over 10% in the next 2 years driven by occupancy, case mix improvement, and inflationary price increases. - New Dombivli hospital is ramping up with an EBITDA breakeven expected by end of 2 years of operation. - Expansion plans include 1,700 new beds across projects, aiming for a network of nearly 3,000 beds. - Internal accruals and controlled debt levels expected to support growth and capex. Overall, growth drivers include occupancy increase, case mix improvement, insurance renewals with price hikes, and capacity expansion.

- **Dombivli Hospital**: Expected EBITDA breakeven by end of calendar year 2027 or early 2028 (about 2 years of operation). Monthly EBITDA burn currently INR 2-3 crores. - **Indore Facility**: Occupancy is under 50%, expected to improve over next 1-2 years leading to near maturity in 2-3 years; case mix and occupancy growth will drive ARPOB and revenues. - **Base Business Growth**: Thane at ~75% occupancy expected to grow at inflation-linked rates (~10%+), Pune with capacity headroom to grow via occupancy and pricing, Indore ramping up adding growth. - **ARPOB**: Increased 11.7% to INR 67,700 driven by improved case mix and insurance-driven price hikes. - **Capex Funding**: Internal accruals plus debt under 3x EBITDA planned to fund expansions without liquidity issues. - **Long-term Capacity**: Expanding to ~3,000 beds over next few years supporting revenue growth.

- The company is undertaking a significant expansion cycle, adding approximately 1,700 new beds, which will take their long-term capacity to nearly 3,000 beds. - The expansion projects include Dombivli (recently commissioned), Pune South (on track to open in calendar year 2028), Mira Road (architectural drawings completed, regulatory clearances underway, excavation expected by year-end), and BKC (a 400-bed quaternary care hospital in Mumbai). - Land allotment for BKC has been received; prepossession formalities with MMRDA are ongoing. - Capex for these projects is expected to be met through internal accruals and debt, with a self-imposed ceiling of 3 times EBITDA. - No specific orderbook or pending order values are mentioned, but INR500 crores capex was deployed this year, including land payment and ongoing projects. - Accreditation and insurance empanelment processes for Dombivli are underway; occupancy ramp-up is in progress.